Ubs Group AG

UBS Group AG reported the disposal of 1,022 shares of Auction Preferred Stock in Eaton Vance Senior Income Trust.

UBS Group AG reported the disposal of 5,148 shares of Auction Preferred Stock in the Eaton Vance Ltd Duration Income Fund.

UBS Group AG reported the disposal of 1,973 shares of Eaton Vance Senior Floating-Rate Trust Auction Preferred Stock.

UBS Group AG reports the sale of Global Star Acquisition Inc. shares, resulting in a decrease in their beneficial ownership.

UBS Group AG files an amended Form 4 to correct an initial filing, clarifying that it never beneficially owned more than 10% of ENDRA Life Sciences shares due to warrant exercises affecting the total outstanding share count.

UBS Group AG, through its subsidiaries, reports transactions involving ENDRA Life Sciences Inc. common stock, resulting in adjustments to its beneficial ownership.

UBS Group AG has filed its quarterly 13F holdings report for the period ending March 31, 2026, detailing a significant portfolio of managed assets.

UBS Group AG filed its quarterly 13F-HR report, disclosing holdings as of June 30, 2025.

UBS Group AG filed its 13F holdings report, revealing its investment portfolio as of March 31, 2025.

UBS Group AG's latest 13F-HR filing reveals a vast and diversified portfolio, with significant investments across various sectors and asset classes.

Financial giant UBS Group AG has disclosed its investment holdings as of September 30, 2024, showcasing significant portfolio adjustments and strategic bets across various sectors.

Financial giant UBS Group AG has disclosed its holdings as of June 30, 2024, in its latest Form 13F-HR filing with the Securities and Exchange Commission.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 5.45% of Rising Dragon Acquisition Corp.'s common stock.

UBS Group AG has filed a Schedule 13G detailing its beneficial ownership of Starlink AI Acquisition Corp units, holding 5.4% of the class.

UBS Group AG has filed a Schedule 13G, reporting beneficial ownership of 30.0% of abrdn Income Credit Strategies Fund's 5.250% Series A Perpetual Preferred Shares.

UBS Group AG has filed a Schedule 13G, disclosing beneficial ownership of 2,170,665 common shares, representing 6.6% of the outstanding shares in Nuveen California Municipal Value Fund.

UBS Group AG has filed a Schedule 13G, reporting no beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock as of June 30, 2026.

UBS Group AG has filed an amendment to its Schedule 13G, correcting the event date for its previous filing concerning AMC Entertainment Holdings, Inc. Class A common stock.